| Structure | Chemical Name | CAS | MF |
|
1H-Indole-2,3-dione,1-ethyl-,3-(methylhydrazone)(9CI)
|
455300-56-8
|
C11H13N3O
|
|
ALIZARIN COMPLEXONE DIHYDRATE, INDICATOR GRADE, PURE
|
455303-00-1
|
C19H17NO9
|
|
2,6-Piperazinedione,4-(2-propynyl)-(9CI)
|
455311-31-6
|
C7H8N2O2
|
|
2,6-Piperazinedione,1-(hydroxymethyl)-4-(2-propynyl)-(9CI)
|
455311-32-7
|
C8H10N2O3
|
|
1H-Benzimidazole-1-ethanol, 2,3-dihydro-2-imino-alpha-(phenoxymethyl)-3-(phenylmethyl)- monohydrochloride
|
455311-98-5
|
C23H24ClN3O2
|
|
Methyl 4-(4-piperidinyloxy)benzoate hydrochloride
|
455323-66-7
|
C13H18ClNO3
|
|
8-Azabicyclo[3.2.1]octane-2,3,6-triol, (1S,2R,3R,5S,6R)- (9CI)
|
455325-03-8
|
C7H13NO3
|
|
8-Azabicyclo[3.2.1]octane-2,3,4-triol, (1R,2S,3-exo,4R,5S)-rel- (9CI)
|
455325-05-0
|
C7H13NO3
|
|
(Z)-N-phenyl-4-(piperidin-1-yl)-6-(2-(quinuclidin-3-ylidene)hydrazinyl)-1,3,5-triazin-2-aMine
|
455325-51-6
|
C21H28N8
|
|
Borate(1-), tetrakis[3,5-bis(trifluoroMethyl)phenyl]-, sodiuM, hydrate (9CI)
|
455330-37-7
|
C32H14BF24NaO
|
|
Carbamic acid, [(1R)-4-oxo-2-cyclohexen-1-yl]-, 1,1-dimethylethyl ester (9CI)
|
455330-42-4
|
C11H17NO3
|
|
Glycine, N-3-butenyl-, ethyl ester (9CI)
|
455333-83-2
|
C8H15NO2
|
|
D-Proline, 4-hydroxy-5-oxo-, ethyl ester, (4R)- (9CI)
|
455334-20-0
|
C7H11NO4
|
|
CpG2007
|
455348-63-7
|
|
|
1H-Inden-1-amine, 2,3-dihydro-N-nitroso-N-(phenylmethyl)-, (1R)-
|
455884-56-7
|
C16H16N2O
|
|
|
Gumarabic,hydrogenoctenylbutanedioate
|
455885-22-0
|
|
|
7-broMo-1,2,3,4-tetrahydro-5H-1,4-Benzodiazepin-5-one
|
455885-78-6
|
C9H9BrN2O
|
|
N-(3,4-Dimethoxyphenyl)(2-nitrophenyl)formamide
|
455887-65-7
|
C15H14N2O5
|
|
2-(4-Bromo-2,6-dimethylphenoxy)acetic acid
|
455887-97-5
|
C10H11BrO3
|
|
6-iodo-N-propylquinazolin-4-amine
|
455889-00-6
|
C11H12IN3
|
|
Phosphoramidic acid, (1-oxopropyl)-, dimethyl ester (9CI)
|
455891-99-3
|
C5H12NO4P
|
|
2,4-Cyclooctadien-1-one, 2-amino-4-hydroxy- (9CI)
|
455892-95-2
|
C8H11NO2
|
|
2,4-Cyclooctadien-1-one, 4-amino-2-hydroxy- (9CI)
|
455892-96-3
|
C8H11NO2
|
|
1(3aH)-Pentalenone,4,5,6,6a-tetrahydro-3,3a-dihydroxy-,(3aR,6aR)-rel-(9CI)
|
455892-99-6
|
C8H10O3
|
|
3a(1H)-Pentalenol,3-amino-4,5,6,6a-tetrahydro-1-imino-,(3aR,6aS)-rel-(9CI)
|
455893-05-7
|
C8H12N2O
|
|
1(3aH)-Pentalenone, 3-amino-4,5,6,6a-tetrahydro-3a-hydroxy-, (3aR,6aR)-rel- (9CI)
|
455893-06-8
|
C8H11NO2
|
|
1,6a(3H)-Pentalenediol, 3a,4,5,6-tetrahydro-3-imino-, (3aR,6aS)-rel- (9CI)
|
455893-07-9
|
C8H11NO2
|
|
7-Oxabicyclo[4.1.0]heptane-1-carbonitrile,2-fluoro-2-methyl-,(1R,2S,6R)-
|
455935-72-5
|
C8H10FNO
|
|
1-Oxaspiro[2.4]heptane-2-carboxylicacid,2-methyl-(9CI)
|
455935-81-6
|
C8H12O3
|
|
(alphaS)-alpha-Amino-1-methylcyclohexaneacetic acid
|
455936-38-6
|
C9H17NO2
|
|
9aH-Quinolizin-9a-amine,octahydro-(9CI)
|
455937-27-6
|
C9H18N2
|
|
2-Pyridinecarboxylic acid, 4-(trifluoromethyl)-, methyl ester
|
455941-78-3
|
C8H6F3NO2
|
|
Methyl 3-bromo-4-(trifluoromethyl)benzoate
|
455941-82-9
|
C9H6BrF3O2
|
|
3,3',5,5'-Tetrakis(MethoxyMethyl)-[1,1'-biphenyl]-4,4'-diol
|
455943-61-0
|
C20H26O6
|
|
9H-Fluorene-2,7-disulfonic acid, 9,9-bis(4-aminophenyl)-
|
455944-24-8
|
C25H20N2O6S2
|
|
1,4-Bis[(4-ethenylphenyl)methyl]piperazine
|
455947-51-0
|
C22H26N2
|
|
3'-Deoxy-2'-thiouridine
|
455951-69-6
|
C9H12N2O4S
|
|
Biotinyl-εAhx-SCC1 (263-268)-2,4,6-trimethylbenzoyloxy-methylketone
|
455951-99-2
|
C53H83N13O15S
|
|
4-(4-Fluoro-phenyl)-pyrrolidine-1,3-dicarboxylic acid 1-tert-butyl ester
|
455954-94-6
|
C16H20FNO4
|
|
N-(Methoxymethyl)-2-methyl-N-[(trimethylsilyl)-methyl]-2-propanamine
|
455954-96-8
|
C10H25NOSi
|
|
2-Phenyl-pyrrolidine-1,3-dicarboxylic acid 1-tert-butyl ester
|
455955-08-5
|
C16H21NO4
|
|
2-Chloro-5-fluoroquinoline
|
455955-27-8
|
C9H5ClFN
|
|
3-Pyrrolidinecarboxylic acid, 4-(2,4-difluorophenyl)-1-(1,1-dimethylethyl)-, methyl ester, (3S,4R)-
|
455957-73-0
|
C16H21F2NO2
|
|
Methyl 2-(2-broMo-5-chlorophenyl)acetate
|
455957-76-3
|
C9H8BrClO2
|
|
2-bromo-5-chloro-N-methoxy-N-methylbenzamide
|
455957-87-6
|
C9H9BrClNO2
|
|
(3S,4R)-1-tert-Butyl-4-(2,4-difluorophenyl)pyrrolidine-3-carboxylic acid
|
455957-94-5
|
C15H19F2NO2
|
|
3-(4-Bromo-5-methyl-pyrazol-1-yl)-propionic acid
|
456396-56-8
|
C7H9BrN2O2
|
|
tert-butyl (S)-(3-amino-4
-(benzylamino)-4-oxobutyl)carbamate
|
456527-46-1
|
C16H25N3O3
|
|
1alpha, 24, 25-Trihydroxy VD2
|
457048-34-9
|
C28H44O4
|
|
Benzenesulfonyl fluoride, 5-bromo-2-methoxy-
|
457051-09-1
|
C7H6BrFO3S
|
|
Benzonitrile, 4-broMo-2-(broMoMethyl)-
|
457051-12-6
|
C8H5Br2N
|
|
5-bromo-2-chlorobenzenesulfonic acid
|
457051-14-8
|
C6H4BrClO3S
|
|
4-bromo-2-fluoro-6-methoxybenzonitrile
|
457051-15-9
|
C8H5BrFNO
|
|
2-Furancarboxylicacid,5-(1H-pyrazol-1-ylmethyl)-,hydrazide(9CI)
|
457051-27-3
|
C9H10N4O2
|
|
4-(1H-benzo[d][1,2,3]triazol-1-yl)-1-methylpyridin-1-ium iodide
|
457051-53-5
|
C12H11IN4
|
|
Benzoxazole, 2-(2-pyridinylmethyl)-
|
457053-50-8
|
C13H10N2O
|
|
Methyl4-methyl-5-thiazolecarboxylate
|
457054-15-8
|
C30H28ClCuN4O4S4+
|
|
S-3-Cyclopropylalanine tert-butyl ester
|
457059-27-7
|
C10H19NO2
|
|
2-Butanone, 4-(1-oxopropoxy)- (9CI)
|
457060-45-6
|
C7H12O3
|
|
2-(FMoc-aMino)-3-(1-Boc-3-piperidyl)propanoic Acid
|
457060-97-8
|
C28H34N2O6
|
|
8-BroMo-2-iodoadenosine
|
457060-99-0
|
C10H11BrIN5O4
|
|
2-Fluoro-4-(tributylstanny)lpyridine
|
457061-31-3
|
C17H30FNSn
|
|
3-Methoxy-5,5,8,8-tetraMethyl-5,6,7,8-tetrahydronaphthalen-2-aMine
|
457065-49-5
|
C15H23NO
|
|
1,3,3,5,5-pentamethylcyclohexylamine methanesulfonate
|
457068-92-7
|
C11H23N.CH4O3S
|
|
Butanenitrile, 2-(hydroxymethylene)-3-oxo- (9CI)
|
457069-60-2
|
C5H5NO2
|
|
Cytostatin (sodium salt)
|
457070-06-3
|
C21H34NaO7P
|
|
Buprenorphine Related Compound A CII (25 mg) (21-[3-(1-Propenyl)]-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine)
|
457071-73-7
|
C29H41NO4
|
|
ba-D-erythro-Hexopyranos-4-ulose, 6-deoxy-5-C-methyl-, 1-acetate (9CI)
|
457080-88-5
|
C9H14O6
|
|
alpha-L-lyxo-Hexopyranose, 6-deoxy-5-C-methyl-, 1-acetate (9CI)
|
457080-89-6
|
C9H16O6
|
|
JAK INHIBITOR I
|
457081-03-7
|
C18H16FN3O
|
|
(R)-tert-Butyl 1-(pyridin-2-ylmethyl)pyrrolidin-3-ylcarbamate
|
457097-72-2
|
C15H23N3O2
|
|
3-Pyrrolidinamine,1-methyl-,(3R)-(9CI)
|
457097-75-5
|
C5H12N2
|
|
(R)-1-(Cyclohexylmethyl)pyrrolidin-3-amine
|
457097-82-4
|
C11H22N2
|
|
Methyl 4-amino-3-(trifluoromethoxy)benzoate
|
457097-93-7
|
C9H8F3NO3
|
|
(S)-tert-Butyl 1-(4-fluorobenzyl)pyrrolidin-3-ylcarbamate
|
457097-99-3
|
C16H23FN2O2
|
|
(S)-1-(4-Fluorobenzyl)pyrrolidin-3-amine
|
457098-00-9
|
C11H15FN2
|
|
N-[3-(2-Amino-4-methylphenoxy)propyl]-N,N-dimethylamine
|
457098-40-7
|
C12H20N2O
|
|
5-Methyl-2-(3-pyridinyloxy)aniline
|
457099-14-8
|
C12H12N2O
|
|
Pyrazinamine, 4,5-dihydro-4-methyl- (9CI)
|
457099-20-6
|
C5H9N3
|
|
5-ethynylpyrazin-2-aMine
|
457099-42-2
|
C6H5N3
|
|
Benzenamine, 2-methoxy-4-(methoxymethyl)- (9CI)
|
457099-52-4
|
C9H13NO2
|
|
C30(-hydroxy) Ceramide (d18:1/30:0)
|
457100-08-2
|
C48H95NO4
|
|
SalicylaldehydeHydrazone98%
|
45744-148-1
|
C7H8N2O
|
|
2-Propenenitrile, 3-(4-acetylphenyl)- (9CI)
|
457602-70-9
|
C11H9NO
|
|
Cholestan-6-one, 2,3,14,20,22,25-hexahydroxy-, (2β,3β,5β,22R)-
|
457603-63-3
|
C27H46O7
|
|
2-Furanacetic acid, 3-ethyl-2,5-dihydro-4-hydroxy-5-oxo-, ethyl ester, (2S)- (9CI)
|
457604-25-0
|
C10H14O5
|
|
3-Pyridinecarbonitrile, 1,2-dihydro-6-hydroxy-2-oxo-1,4-dipropyl- (9CI)
|
457604-60-3
|
C12H16N2O2
|
|
3-Pyridinecarbonitrile, 1,2-dihydro-6-hydroxy-1-(1-methylethyl)-2-oxo-4-propyl- (9CI)
|
457604-61-4
|
C12H16N2O2
|
|
3-Pyridinecarbonitrile, 1,2-dihydro-6-hydroxy-1,4-bis(1-methylethyl)-2-oxo- (9CI)
|
457604-62-5
|
C12H16N2O2
|
|
CZEN-002
|
457605-12-8
|
C42H74N12O10S2
|
|
2-(4-bromophenyl)-4,6-diphenylpyrimidine
|
457613-56-8
|
C22H15BrN2
|
|
(4-[4-(tert-Butoxycarbonyl)piperazin-1-yl]phenyl)boronic acid
|
457613-78-4
|
C15H23BN2O4
|
|
1-Methyl-3-(tetrahydro-3-furylmethyl)guanidium dihydrogen (DN) Solution, 100ppm
|
457614-32-3
|
C7H15N3O
|
|
1-Methyl-3-(tetrahydro-3-furylmethyl) urea (UF) Solution, 100ppm
|
457614-34-5
|
C7H14N2O2
|
|
DL-N-acetyl-4-iodo- Phenylalanine
|
457615-88-2
|
C11H12INO3
|
|
Acetamide, N-(4-ethylphenyl)-2-(2-propenylamino)- (9CI)
|
457617-18-4
|
C13H18N2O
|
|
2-(2-Chloro-acetylamino)-4-(4-chloro-phenyl)-thiophene-3-carboxylic acid ethyl ester
|
457621-54-4
|
C15H13Cl2NO3S
|
|
3-Thiophenecarboxylic acid, 2-[(3-chloro-1-oxopropyl)amino]-4-(4-chlorophenyl)-, ethyl ester
|
457621-59-9
|
C16H15Cl2NO3S
|
|
4-Piperidineaceticacid,5-ethyl-2-oxo-,ethylester,(4R,5S)-(9CI)
|
457623-01-7
|
C11H19NO3
|
|
Ethanone, 1-[(2S,6S)-3,6-dihydro-6-methoxy-5-methyl-2H-pyran-2-yl]- (9CI)
|
457623-06-2
|
C9H14O3
|